Empirical Finance’s United Therapeutics UTHR Stock Holding History

Empirical Finance’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.9M	Hold	3,210	–	–	0.09%	191
2025 Q4	$1.56M	Hold	3,210	–	–	0.07%	210
2025 Q3	$1.35M	Buy	3,210 +18	+0.6%	+$6.05K	0.06%	252
2025 Q2	$917K	Buy	3,192 +895	+39%	+$267K	0.05%	324
2025 Q1	$708K	Hold	2,297	–	–	0.04%	345
2024 Q4	$810K	Sell	2,297 -2,076	-47%	-$763K	0.05%	311
2024 Q3	$1.57M	Buy	4,373 +18	+0.4%	+$6.08K	0.09%	187
2024 Q2	$1.39M	Buy	4,355 +322	+8%	+$85.2K	0.09%	191
2024 Q1	$926K	Buy	4,033 +16	+0.4%	+$3.61K	0.06%	292
2023 Q4	$883K	Hold	4,017	–	–	0.06%	280
2023 Q3	$907K	Buy	4,017 +267	+7%	+$61.5K	0.07%	255
2023 Q2	$828K	Buy	3,750 +1,942	+107%	+$430K	0.06%	268
2023 Q1	$405K	Hold	1,808	–	–	0.04%	396
2022 Q4	$503K	Buy	1,808 +12	+0.7%	+$3.03K	0.05%	328
2022 Q3	$376K	Buy	+1,796	New	+$402K	0.04%	356
2021 Q4	–	Sell	-4,400	Closed	-$812K	–	467
2021 Q3	$812K	Sell	4,400 -5,387	-55%	-$1.06M	0.12%	168
2021 Q2	$1.76M	Sell	9,787 -12,324	-56%	-$2.35M	0.29%	67
2021 Q1	$3.36M	Hold	22,111	–	–	0.59%	28
2020 Q4	$3.36M	Hold	22,111	–	–	0.59%	28
2020 Q3	$2.23M	Sell	22,111 -3,795	-15%	-$416K	0.48%	44
2020 Q2	$3.13M	Buy	25,906 +221	+0.9%	+$24.9K	0.8%	16
2020 Q1	$2.44M	Buy	25,685 +3,935	+18%	+$374K	0.76%	17
2019 Q4	$1.92M	Sell	21,750 -3,393	-13%	-$299K	0.47%	30
2019 Q3	$2M	Buy	25,143 +16,809	+202%	+$1.35M	0.56%	30
2019 Q2	$651K	Buy	8,334 +44	+0.5%	+$4.12K	0.18%	100
2019 Q1	$973K	Buy	+8,290	New	+$966K	0.25%	84
2018 Q4	–	Sell	-20,867	Closed	-$2.67M	–	180
2018 Q3	$2.67M	Buy	20,867 +3,896	+23%	+$482K	0.66%	19
2018 Q2	$1.92M	Buy	16,971 +8,681	+105%	+$954K	0.49%	38
2018 Q1	$973K	Sell	8,290 -604	-7%	-$76.7K	0.25%	84
2017 Q4	$1.32M	Sell	8,894 -6,712	-43%	-$853K	0.43%	64
2017 Q3	$1.83M	Buy	15,606 +1,190	+8%	+$152K	0.63%	36
2017 Q2	$1.87M	Buy	14,416 +14	+0.1%	+$1.75K	0.72%	28
2017 Q1	$1.95M	Buy	14,402 +5,797	+67%	+$878K	0.92%	21
2016 Q4	$1.24M	Buy	+8,605	New	+$1.1M	0.84%	21